BridgeMD
Defining Antibiotic Levels in Intensive care patients (DALI-2) protocol
EU CTIS ID: 2024-516232-10-00
What this study is testing
1. To describe the achievement of therapeutic antibiotic exposures (concentrations) in critically ill patients
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- 1. Patient is admitted to an ICU
- 2. Patient receiving one of the specified intravenous antibiotics (see Table 2) for the treatment of infection
- 3. Suitable intravenous/intra-arterial access to facilitate sample collection
- 4. Corrected gestational age of patient ≥1 month.
- 5. The patient must have been administered the study antibiotic for at least 24 hours.
- 6. Informed consent to participate in the study.
You likely can't join if
- 1. Patient’s death is deemed imminent and inevitable
- 2. Patients who have received the study antibiotic for a duration exceeding 96 hours without accompanying blood sample collection
- 3. Patient is in a period of exclusion from a previous study, or is already participating in another research study involving a drug or which may influence the primary endpoint
- The patient is under court protection or guardianship
The study team makes the final eligibility decision.
Where it's taking place
- Taiwan
- Israel
- United Kingdom
- Thailand
- Brazil
- United States
- Chile
- Singapore
- Iran, Islamic Republic of
- Kazakhstan
- South Africa
- Pakistan
- Japan
- Qatar
- Australia
- Vietnam
- China
- Hong Kong
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65+ years, 18-64 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Taiwan; Israel; United Kingdom; Thailand; Brazil; United States and 12 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.